{
    "nct_id": "NCT03559218",
    "official_title": "Pilot Study: KeraStat(R) Cream for Radiation Dermatitis",
    "inclusion_criteria": "1. Age 18 to 70\n2. Female\n3. Diagnosis of breast cancer and scheduled to receive 4 to 6 weeks of radiation therapy (radiation dose of 42 Gy or more)\n4. Able and willing to sign protocol consent form\n5. Able and willing to document symptoms and treatment details as often as needed, not to exceed daily notes\n6. Able and willing to have photographs of the affected area taken regularly\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 70 Years",
    "exclusion_criteria": "1. Women who are pregnant, lactating/nursing or plan to become pregnant\n2. Previous radiation therapy to the area to be treated with radiation therapy\n3. Receiving palliative radiation therapy\n4. Unhealed or infected surgical sites in the irradiation area\n5. Patients undergoing cytotoxic chemotherapy or concurrent Herceptin as part of overall treatment plan (tamoxifen/aromatase inhibitor allowed)\n6. Use of oral corticosteroids or topical corticosteroids in the irradiation area\n7. Autoimmune disease\n8. Skin disease in target irradiation area\n9. Known allergy to the standard of care or ingredients in KeraStat Cream",
    "miscellaneous_criteria": ""
}